US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 1.020
  • +0.020+2.00%
Close Mar 17 16:00 ET
  • 1.020
  • 0.000-0.04%
Pre 08:20 ET
65.53MMarket Cap-0.63P/E (TTM)

Inozyme Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.04%-91.91M
-3.79%-19.19M
-30.00%-24.53M
-52.16%-23.66M
-38.04%-24.53M
-22.36%-70.68M
-28.38%-18.49M
-30.00%-18.87M
-5.86%-15.55M
-25.51%-17.77M
Net income from continuing operations
-43.35%-102.02M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
Operating gains losses
----
----
----
----
----
17.65%20K
----
----
----
----
Depreciation and amortization
-10.92%742K
-15.31%177K
-6.25%195K
-10.05%188K
-12.08%182K
11.96%833K
5.56%209K
10.05%208K
16.76%209K
16.29%207K
Other non cash items
56.14%1.76M
39.22%465K
45.05%454K
56.79%439K
101.52%397K
113.69%1.12M
85.56%334K
128.47%313K
164.15%280K
91.26%197K
Change In working capital
252.95%4.71M
98.80%5.82M
34.67%-1.92M
327.26%2.16M
36.73%-1.34M
-253.18%-3.08M
19.10%2.93M
-1,751.12%-2.94M
31.61%-950K
-376.14%-2.12M
-Change in prepaid assets
145.42%917K
79.15%1.35M
69.38%-890K
-317.24%-726K
283.17%1.18M
-421.71%-2.02M
-20.49%753K
-31.78%-2.91M
-132.10%-174K
-6.36%309K
-Change in payables and accrued expense
3,926.83%4.71M
97.23%4.7M
-563.01%-801K
689.02%3.11M
-7.06%-2.3M
-104.09%-123K
51.37%2.38M
-93.20%173K
69.39%-528K
-450.49%-2.15M
-Change in other current liabilities
3.19%-910K
-11.32%-236K
-11.71%-229K
9.27%-225K
20.00%-220K
-54.61%-940K
-221.21%-212K
-11.41%-205K
-37.02%-248K
-55.37%-275K
Cash from discontinued investing activities
Operating cash flow
-30.04%-91.91M
-3.79%-19.19M
-30.00%-24.53M
-52.16%-23.66M
-38.04%-24.53M
-22.36%-70.68M
-28.38%-18.49M
-30.00%-18.87M
-5.86%-15.55M
-25.51%-17.77M
Investing cash flow
Cash flow from continuing investing activities
224.89%67M
338.64%15.44M
152.33%23.35M
209.12%17.82M
-24.50%10.39M
-892.89%-53.65M
-301.06%-6.47M
-440.33%-44.62M
28.78%-16.33M
-38.99%13.77M
Net PPE purchase and sale
79.19%-62K
83.81%-17K
-85.71%-13K
--0
81.71%-32K
27.32%-298K
-128.26%-105K
95.24%-7K
94.50%-11K
-929.41%-175K
Net investment purchase and sale
225.70%67.06M
342.84%15.46M
152.37%23.36M
209.19%17.82M
-25.21%10.43M
-968.46%-53.35M
-295.01%-6.37M
-450.04%-44.61M
28.21%-16.32M
-38.26%13.94M
Cash from discontinued investing activities
Investing cash flow
224.89%67M
338.64%15.44M
152.33%23.35M
209.12%17.82M
-24.50%10.39M
-892.89%-53.65M
-301.06%-6.47M
-440.33%-44.62M
28.78%-16.33M
-38.99%13.77M
Financing cash flow
Cash flow from continuing financing activities
-90.95%11.4M
-97.94%258K
-84.91%10.52M
-98.06%458K
-99.21%159K
73.06%125.97M
12.52M
1,553.97%69.72M
-65.40%23.64M
8,273.33%20.1M
Net issuance payments of debt
--0
--0
--0
--0
--0
887.65%40M
--12.5M
--0
--7.5M
--20M
Net common stock issuance
-87.72%10.52M
4,150.00%81K
-84.99%10.44M
----
----
52.57%85.65M
---2K
165,723.81%69.56M
----
----
Proceeds from stock option exercised by employees
172.36%877K
883.33%177K
-45.75%83K
732.73%458K
65.63%159K
-97.44%322K
--18K
-26.09%153K
-99.55%55K
-60.00%96K
Cash from discontinued financing activities
Financing cash flow
-90.95%11.4M
-97.94%258K
-84.91%10.52M
-98.06%458K
-99.21%159K
73.06%125.97M
--12.52M
1,553.97%69.72M
-65.40%23.64M
8,273.33%20.1M
Net cash flow
Beginning cash position
4.90%34.9M
-47.28%24.89M
-62.23%15.54M
-57.61%20.93M
4.90%34.9M
40.55%33.27M
6.32%47.21M
-34.65%41.16M
52.89%49.38M
40.55%33.27M
Current changes in cash
-919.84%-13.51M
71.95%-3.49M
49.92%9.34M
34.60%-5.38M
-186.89%-13.98M
-82.88%1.65M
-11.26%-12.44M
133.58%6.23M
-126.80%-8.23M
86.18%16.09M
Effect of exchange rate changes
122.22%4K
-102.99%-4K
99.45%-1K
-109.09%-1K
-47.37%10K
28.00%-18K
152.83%134K
-810.00%-182K
125.58%11K
226.67%19K
End cash Position
-38.70%21.39M
-38.70%21.39M
-47.28%24.89M
-62.23%15.54M
-57.61%20.93M
4.90%34.9M
4.90%34.9M
6.32%47.21M
-34.65%41.16M
52.89%49.38M
Free cash flow
-29.58%-91.97M
-3.30%-19.21M
-30.02%-24.54M
-52.05%-23.66M
-36.88%-24.57M
-22.01%-70.97M
-28.70%-18.59M
-28.74%-18.88M
-4.51%-15.56M
-26.59%-17.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.04%-91.91M-3.79%-19.19M-30.00%-24.53M-52.16%-23.66M-38.04%-24.53M-22.36%-70.68M-28.38%-18.49M-30.00%-18.87M-5.86%-15.55M-25.51%-17.77M
Net income from continuing operations -43.35%-102.02M-25.67%-27.07M-47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M
Operating gains losses --------------------17.65%20K----------------
Depreciation and amortization -10.92%742K-15.31%177K-6.25%195K-10.05%188K-12.08%182K11.96%833K5.56%209K10.05%208K16.76%209K16.29%207K
Other non cash items 56.14%1.76M39.22%465K45.05%454K56.79%439K101.52%397K113.69%1.12M85.56%334K128.47%313K164.15%280K91.26%197K
Change In working capital 252.95%4.71M98.80%5.82M34.67%-1.92M327.26%2.16M36.73%-1.34M-253.18%-3.08M19.10%2.93M-1,751.12%-2.94M31.61%-950K-376.14%-2.12M
-Change in prepaid assets 145.42%917K79.15%1.35M69.38%-890K-317.24%-726K283.17%1.18M-421.71%-2.02M-20.49%753K-31.78%-2.91M-132.10%-174K-6.36%309K
-Change in payables and accrued expense 3,926.83%4.71M97.23%4.7M-563.01%-801K689.02%3.11M-7.06%-2.3M-104.09%-123K51.37%2.38M-93.20%173K69.39%-528K-450.49%-2.15M
-Change in other current liabilities 3.19%-910K-11.32%-236K-11.71%-229K9.27%-225K20.00%-220K-54.61%-940K-221.21%-212K-11.41%-205K-37.02%-248K-55.37%-275K
Cash from discontinued investing activities
Operating cash flow -30.04%-91.91M-3.79%-19.19M-30.00%-24.53M-52.16%-23.66M-38.04%-24.53M-22.36%-70.68M-28.38%-18.49M-30.00%-18.87M-5.86%-15.55M-25.51%-17.77M
Investing cash flow
Cash flow from continuing investing activities 224.89%67M338.64%15.44M152.33%23.35M209.12%17.82M-24.50%10.39M-892.89%-53.65M-301.06%-6.47M-440.33%-44.62M28.78%-16.33M-38.99%13.77M
Net PPE purchase and sale 79.19%-62K83.81%-17K-85.71%-13K--081.71%-32K27.32%-298K-128.26%-105K95.24%-7K94.50%-11K-929.41%-175K
Net investment purchase and sale 225.70%67.06M342.84%15.46M152.37%23.36M209.19%17.82M-25.21%10.43M-968.46%-53.35M-295.01%-6.37M-450.04%-44.61M28.21%-16.32M-38.26%13.94M
Cash from discontinued investing activities
Investing cash flow 224.89%67M338.64%15.44M152.33%23.35M209.12%17.82M-24.50%10.39M-892.89%-53.65M-301.06%-6.47M-440.33%-44.62M28.78%-16.33M-38.99%13.77M
Financing cash flow
Cash flow from continuing financing activities -90.95%11.4M-97.94%258K-84.91%10.52M-98.06%458K-99.21%159K73.06%125.97M12.52M1,553.97%69.72M-65.40%23.64M8,273.33%20.1M
Net issuance payments of debt --0--0--0--0--0887.65%40M--12.5M--0--7.5M--20M
Net common stock issuance -87.72%10.52M4,150.00%81K-84.99%10.44M--------52.57%85.65M---2K165,723.81%69.56M--------
Proceeds from stock option exercised by employees 172.36%877K883.33%177K-45.75%83K732.73%458K65.63%159K-97.44%322K--18K-26.09%153K-99.55%55K-60.00%96K
Cash from discontinued financing activities
Financing cash flow -90.95%11.4M-97.94%258K-84.91%10.52M-98.06%458K-99.21%159K73.06%125.97M--12.52M1,553.97%69.72M-65.40%23.64M8,273.33%20.1M
Net cash flow
Beginning cash position 4.90%34.9M-47.28%24.89M-62.23%15.54M-57.61%20.93M4.90%34.9M40.55%33.27M6.32%47.21M-34.65%41.16M52.89%49.38M40.55%33.27M
Current changes in cash -919.84%-13.51M71.95%-3.49M49.92%9.34M34.60%-5.38M-186.89%-13.98M-82.88%1.65M-11.26%-12.44M133.58%6.23M-126.80%-8.23M86.18%16.09M
Effect of exchange rate changes 122.22%4K-102.99%-4K99.45%-1K-109.09%-1K-47.37%10K28.00%-18K152.83%134K-810.00%-182K125.58%11K226.67%19K
End cash Position -38.70%21.39M-38.70%21.39M-47.28%24.89M-62.23%15.54M-57.61%20.93M4.90%34.9M4.90%34.9M6.32%47.21M-34.65%41.16M52.89%49.38M
Free cash flow -29.58%-91.97M-3.30%-19.21M-30.02%-24.54M-52.05%-23.66M-36.88%-24.57M-22.01%-70.97M-28.70%-18.59M-28.74%-18.88M-4.51%-15.56M-26.59%-17.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.